Latest Breaking News On - Abdul rafeh naqash - Page 1 : vimarsana.com

Addition of immunotherapy to perioperative cancer treatment linked to more toxicity

Cancer test shows promise for bringing the benefits of immunotherapy to more patients

Promising Cancer Test May Expand Immunotherapy Benefits

Immunotherapy Increases Risk of Side Effects, But Not Death

A recent study showed that incorporating immunotherapy checkpoint blockade into treatment before and after surgery can increase treatment-related side effects.

14 Best Cancer Stocks To Buy Now - Insider Monkey

The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for a growing number of patients.

Cancer drug shortage: FDA mulls overseas chemotherapy imports

Shortages of cisplatin and carboplatin, bedrock cancer treatments, have forced some hospitals to ration the drugs.

FDA weighs importation of chemo drugs from unapproved manufacturers amid shortage

FDA is considering allowing importation of chemotherapy drugs from overseas to address a shortage of cancer drugs in the U.S,

Immune Checkpoint Inhibitors Safe, Effective in Cancer Patients With HIV

Study finds similar survival outcomes among NSCLC patients with and without HIV

OU Health hematologist-oncologist earns research award

Dr. Abdul Rafeh Naqash, a hematologist-oncologist with OU Health Stephenson Cancer Center, has been granted an Impact Award from the Hope Foundation for Cancer Research.

Caris' Precision Oncology Alliance Welcomes the OU Health Stephenson Cancer Center

/PRNewswire/ -- Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to...